| Name | Title | Contact Details |
|---|---|---|
Jessica Crosbie |
VP, Global Insights and Analytics Oncology Business Unit | Profile |
Guillaume Pasquier |
VP, Head of R&D Digital & Information Technology | Profile |
Kimberly Holliday |
VP, Head of Strategic Planning & Transformation | Profile |
Giuseppe Cognetti |
Sr. Director, Head PharmSci Technology | Profile |
Enrico Maldari |
Director, U.S. Regional Security and Crisis Management Advisor | Profile |
Evotec is a Winchester, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company has four product candidates in development. LJPC-501 is La Jolla’s proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension and hepatorenal syndrome. GCS-100 is La Jolla’s first-in-class galectin-3 inhibitor for the potential treatment of chronic kidney disease. LJPC-1010, La Jolla’s second-generation galectin-3 inhibitor, is a more potent and purified derivative of GCS-100 that can be delivered orally for the potential treatment of nonalcoholic steatohepatitis and other diseases characterized by tissue fibrosis. LJPC-401 is La Jolla’s novel formulation of hepcidin for the potential treatment of conditions characterized by iron overload, such as hemochromatosis and beta thalassemia
ParagonRx is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric Biosciences has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.
Stern At Home Therapy is transforming how outpatient therapy is experienced.